IP Library Granted Patent US 9,801,786
Granted Patent B2
US 9,801,786 · App. 14/784,300 · Granted Oct 31, 2017

Drug container closure for mounting on open-topped drug container to form drug reconstitution assemblage for use with needleless syringe

Inventors: Nimrod Lev (Savion, IL); Mordechai Bukhman (Netanya, IL)
Assignee: Medimop Medical Projects Ltd.
A61J1/2089A61J1/2051A61J1/2055A61J1/2096A61J1/10A61J1/1406A61J1/201A61J1/2065
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,801,786
App. No.
14/784,300
Granted
Oct 31, 2017
Kind
B2
Abstract

A drug container closure for mounting on an open-topped drug container to form a ready-to-use drug reconstitution assemblage for use with a needleless syringe. The drug container closure includes a drug container stopper for sealing the drug container and a fluid transfer member with an integral needleless syringe connector and a puncturing cannula. The fluid transfer member is manually disposed along a diametric inverted L-shaped track pair from an initial non-puncturing position to a puncturing position. The inverted L-shaped track pair includes one-way snap members to prevent a user returning the fluid transfer member to an earlier position and indicating progress of the user activation.

Claims (13)

1. A drug container closure for mounting on an open-topped drug container to form a ready-to-use drug reconstitution assemblage for use with a needleless syringe, the open-topped drug container having a drug container rim defining a drug container opening, the drug container closure having a longitudinal centerline and comprising:

(a) a tubular closure housing for securely mounting on the drug container rim, said closure housing including at least one inverted L-shaped track having an open-ended upright access leg, a horizontal priming leg and an upright activation leg, said activation leg having a proximal activation leg end and a distal activation leg end correspondingly adjacent and distal to said priming leg, each said inverted L-shaped track having:

i) an one-way retaining snap member between said open-ended upright access leg and said horizontal priming leg,

ii) an one-way primed snap member between said horizontal priming leg and said proximal activation leg end, and

iii) an one-way activated snap member towards said distal activation leg end;

(b) a drug container stopper securely mounted on said closure housing for sealing the drug container opening on securely mounting said closure housing on the drug container rim; and

(c) a fluid transfer member having an integral needleless syringe connector and a puncturing cannula in flow communication therewith, said needleless syringe connector for attachment of the needleless syringe thereto, said puncturing cannula for puncturing said drug container stopper,

said fluid transfer member being initially disposed along each said horizontal priming leg whereupon, on manual rotation of said fluid transfer member relative to said longitudinal centerline, said fluid transfer member is urged past each said one-way primed snap member to each said proximal activation leg end prior to being manually urged passed each said one-way activated snap member to each said distal activation leg end for puncturing said drug container stopper for flow communication with the drug container.

2. The closure according to claim 1 and further comprising a sleeve exterior to said closure housing for sealing each said inverted L-shaped track to ensure sterility of said puncturing cannula.

3. The closure according to claim 1 and further comprising a sheath on said puncturing cannula.

4. A ready-to-use drug reconstitution assemblage including an open-topped drug container and the drug container closure according to claim 1 mounted thereon.

5. A ready-to-use drug reconstitution assemblage including an open-topped drug container and the drug container closure according to claim 2 mounted thereon.

6. A ready-to-use drug reconstitution assemblage including an open-topped drug container and the drug container closure according to claim 3 mounted thereon.

Assignments (2)
CHANGE OF NAME Recorded May 3, 2018
From: MEDIMOP MEDICAL PROJECTS LTD
To: WEST PHARMA SERVICES IL, LTD.
Reel/Frame 046069/0444 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 14, 2015
From: LEV, NIMROD; BUKHMAN, MORDECHAI
To: MEDIMOP MEDICAL PROJECTS LTD.
Reel/Frame 037281/0772 →
Priority Claims (1)
IL 225734 · Apr 14, 2013 · national
Continuity (1)
Related Publication 20160051446A1 · Feb 25, 2016